Oncogene Contents: Volume 41 Number 11

In this Issue: Review Article Article Correction

Oncogene Contents: Volume 41 Issue 11

Review Article

Phase separation drives tumor pathogenesis and evolution: all roads lead to Rome Xiang Gu , Ai Zhuang , Jie Yu , Peiwei Chai , Renbing Jia et al. Review Article | 08 February 2022 Oncogene 41 | doi:10.1038/s41388-022-02195-z

Article

Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKCβ1 James E. Melnyk , Veronica Steri , Hao G. Nguyen , Y. Christina Hwang , John D. Gordan et al. Article | 27 January 2022 Oncogene 41 | doi:10.1038/s41388-022-02179-z

CircVPS13C promotes pituitary adenoma growth by decreasing the stability of IFITM1 mRNA via interacting with RRBP1 Weiyu Zhang , Siyu Chen , Qiu Du , Piaopiao Bian , Yutong Chen et al. Article | 28 January 2022 Oncogene 41 | doi:10.1038/s41388-022-02186-0

Loss of NFE2L3 protects against inflammation-induced colorectal cancer through modulation of the tumor microenvironment James Saliba , Baptiste Coutaud , Kiran Makhani , Noam Epstein Roth , Jennie Jackson et al. Article | 28 January 2022 Oncogene 41 | doi:10.1038/s41388-022-02192-2

Oncogenesis induced by combined Phf6 and Idh2 mutations through increased oncometabolites and impaired DNA repair Tsung-Chih Chen , Chi-Yuan Yao , Yu-Ren Chen , Chang-Tsu Yuan , Chien-Chin Lin et al. Article | 28 January 2022 Oncogene 41 | doi:10.1038/s41388-022-02193-1

TRIM32 promotes radioresistance by disrupting TC45-STAT3 interaction in triple-negative breast cancer Yan Ma , Haibo Zhang , Cheng Chen , Lixin Liu , Ting Ding et al. Article | 28 January 2022 Oncogene 41 | doi:10.1038/s41388-022-02204-1

Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax Klaudyna Fidyt , Agata Pastorczak , Julia Cyran , Nicholas T. Crump , Agnieszka Goral et al. Article | 28 January 2022 Oncogene 41 | doi:10.1038/s41388-022-02196-y

Methylation-dependent and -independent roles of EZH2 synergize in CDCA8 activation in prostate cancer Yang Yi , Yanqiang Li , Chao Li , Longxiang Wu , Dongyu Zhao et al. Article | 29 January 2022 Oncogene 41 | doi:10.1038/s41388-022-02208-x

METTL3 promotes intrahepatic cholangiocarcinoma progression by regulating IFIT2 expression in an m6A-YTHDF2-dependent manner Qiong-Cong Xu , Yi-Chih Tien , Yin-Hao Shi , Siyun Chen , Ying-Qin Zhu et al. Article | 29 January 2022 Oncogene 41 | doi:10.1038/s41388-022-02185-1

Hyperglycemia-induced oxidative stress promotes tumor metastasis by upregulating vWF expression in endothelial cells through the transcription factor GATA1 Han-Seok Jeong , Da-Hye Lee , Seung-Hoon Kim , Chang-Han Lee , Hyun Mu Shin et al. Article | 29 January 2022 Oncogene 41 | doi:10.1038/s41388-022-02207-y

SMARCA4 biology in alveolar rhabdomyosarcoma Narendra Bharathy , Megan M. Cleary , Jin-Ah Kim , Kiyo Nagamori , Kenneth A. Crawford et al. Article | 29 January 2022 Oncogene 41 | doi:10.1038/s41388-022-02205-0

RNA-binding protein complex LIN28/MSI2 enhances cancer stem cell-like properties by modulating Hippo-YAP1 signaling and independently of Let-7 Hailin Zou , Juan Luo , Yibo Guo , Yuhong Liu , Yun Wang et al. Article | 31 January 2022 Oncogene 41 | doi:10.1038/s41388-022-02198-w

Correction

Correction to: USP1 inhibition destabilizes KPNA2 and suppresses breast cancer metastasis Aihui Ma , Ming Tang , Li Zhang , Boshi Wang , Zhaojuan Yang et al. Correction | 03 February 2022 Oncogene 41 | doi:10.1038/s41388-022-02215-y

Correction: miR-22 promotes stem cell traits via activating Wnt/β-catenin signaling in cutaneous squamous cell carcinoma Shukai Yuan , Peitao Zhang , Liqi Wen , Shikai Jia , Yufan Wu et al. Correction | 04 February 2022 Oncogene 41 | doi:10.1038/s41388-022-02188-y

Correction to: LNC942 promoting METTL14-mediated m 6 A methylation in breast cancer cell proliferation and progression Tong Sun , Zhikun Wu , Xiufang Wang , Yilin Wang , Xiaoyun Hu et al. Correction | 15 February 2022 Oncogene 41 | doi:10.1038/s41388-022-02194-0

Journal Info Submit Manuscript RSS Feed

This email has been sent to ignoble.experiment@arconati.us by Oncogene.

Unsubscribe Manage Alerts Privacy policy Contact us

Springer Nature Limited is a company registered in England and Wales under Company Number 785998 with its registered office at The Campus, 4 Crinan Street, London, N1 9XW, United Kingdom

Nature is part of Springer Nature. © 2022 Springer Nature Limited. All rights reserved.